Found 15 matching trials
Magnetic Resonance Spectroscopy Study of Memantine in Alzheimer's Disease PHASE4 We are studying subjects with mild to moderate Alzheimer's disease who have...
Show More Location
The Litwin-Zucker Research Center
Learn More & Join Trial
A Genetic and Perfusion Study of Response to Cognitive Enhancers in Lewy Body Disease N/A Lewy body spectrum disorders are a common group of neurodegenerative diseas...
Show More Location
Sunnybrook Health Sciences Centre
Learn More & Join Trial
Masitinib in Patients With Mild to Moderate Alzheimer's Disease PHASE3 The purpose of this study is to assess the safety and efficacy of masitinib...
Show More Location
MHAT Sveta Marina
Learn More & Join Trial
The Effects of Repetitive Transcranial Magnetic Stimulation in Patients With Alzheimer's Disease NA Objectives: The purpose of this study was to investigate the effects of hig...
Show More Location
Istanbul Medipol University
Learn More & Join Trial
Withdrawal of Antidementia Drugs in Advanced Dementia (WADAD) NA Dementia is a chronic progressive mental disorder that adversely affects hi...
Show More Location
Centro Hospitalar Universitário de São João
Learn More & Join Trial
Masitinib in Patients With Mild Alzheimer's Disease PHASE3 Masitinib is an orally administered tyrosine kinase inhibitor that targets ...
Show More Location
Institut de la mémoire et Maladie d'Alzheimer, Hôpitaux Universitaires Pitié-Salpêtrière
Learn More & Join Trial
Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment PHASE4 This is a prospective, multicenter, open-label study. Following screening a...
Show More Location
Département de Gérontologie Clinique
Learn More & Join Trial
The Predictive Factors of Good Clinical Response to Cholinesterase Inhibitors in Alzheimer Disease and Mixed Dementia N/A Background and objectives: The aims of this naturalistic study were: to ana...
Show More Location
Multiple Locations
Learn More & Join Trial
Olfactory Deficits and Donepezil Treatment in Cognitively Impaired Elderly PHASE4 Olfactory identification deficits occur in patients with Alzheimer's diseas...
Show More Location
New York State Psychiatric Institute
Learn More & Join Trial
A Study to Determine the Clinical Safety/Tolerability and Exploratory Efficacy of EHT 0202 as Adjunctive Therapy to Acetylcholinesterase Inhibitor in Mild to Moderate Alzheimer's Disease PHASE2 The objective of this 3-month study is to assess the safety and efficacy of...
Show More Location
Hôpital Privé Les Magnolias
Learn More & Join Trial